Articles

Eyenuk To Provide Artificial Intelligence (AI) Eye Screening to Thousands of Italians Through Collaboration With Ambrosian Ophthalmic Center in February

– 30 Centers Across Italy Will Provide AI Eye Screening for Diabetic Retinopathy, the Leading Cause of Vision Loss Among Working-age Adults – LOS ANGELES–Eyenuk Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced today that it is providing EyeArt® AI Eye

Eyenuk, Inc. transitioning to a new logo

Eyenuk’s logo was originally conceived back in early 2013 , to give the viewer the impression of staring at a “real” 3-dimensional eye, while giving it an orange hue to be consistent with the Eyenuk branding. The logo’s font was chosen to serve as a logo on its own when required. Our old logo has

Eyenuk successfully clears HIPAA audit by A-Lign

Eyenuk Inc., a global artificial intelligence (AI) medical technology company, is pleased to announce that it has successfully cleared an independent HIPAA audit. As a leader in real-world AI eye screening for autonomous disease detection, the team at Eyenuk Inc. understands and embraces the responsibility to keep patient data both private and secure, and they

Preventing the preventable: Combating diabetic retinopathy in at-risk women

World Diabetes Day is the world’s largest diabetes awareness campaign. This year’s theme, Women and Diabetes, promotes the importance of access for all women with diabetes to education, treatment and care. Oslo University Hospital/University of Oslo in collaboration with Eyenuk Inc. recently highlighted the importance of early detection of diabetic retinopathy (DR) in women in